Kohout J
Wien Med Wochenschr. 1980 Feb 15;130(3):130-4.
In 98 cases of pulmonary diseases (active and inactive sarcoidosis, idiopathic interstitial lung fibrosis [Hamman-Rich], collagenous diseases, Goodpasture syndrome, alveolar lipoid proteinosis, malignant lymphogranulomatosis and bronchial carcinoma) and in 18 tuberculin and varidase positive, Kveim negative control cases the migration inhibition factor (MIF) was investigated. Migration inhibition of macrophages was induced by the antigens tuberculin, varidase and Kveim's antigen and measured in Mackaness-chambers 24 hours later. Significant migration inhibition by the antigens tuberculin and varidase were seen in control cases, bronchial carcinomas and alveolar lipoid proteinoses. Increased migration indices frequently were found in interstitial lung fibrosis, Goodpasture syndrom and collagenous diseases. Kveim's antigen caused a significant migration inhibition in most cases of active sarcoidosis and in each one single case of collagenose and Hodgkin disease. The use of Kveim's antigen seem to have practical differential diagnostic value in this way.
对98例肺部疾病患者(包括活动期和静止期结节病、特发性间质性肺纤维化[Hamman-Rich型]、胶原病、古德帕斯丘综合征、肺泡脂蛋白沉着症、恶性淋巴肉芽肿病和支气管癌)以及18例结核菌素和链激酶阳性、克维姆试验阴性的对照病例进行了迁移抑制因子(MIF)的研究。用结核菌素、链激酶和克维姆抗原诱导巨噬细胞迁移抑制,并于24小时后在麦凯内斯小室中进行测量。在对照病例、支气管癌和肺泡脂蛋白沉着症中,可见结核菌素和链激酶抗原引起显著的迁移抑制。在间质性肺纤维化、古德帕斯丘综合征和胶原病中,经常发现迁移指数增加。克维姆抗原在大多数活动期结节病病例以及每一例胶原病和霍奇金病病例中均引起显著的迁移抑制。由此看来,使用克维姆抗原具有实际的鉴别诊断价值。